publication venue for Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.. 129:572-581. 2017 Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.. 129:177-187. 2017 Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.. :-. 2015 SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.. 121:148-155. 2013 Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.. 121:485-488. 2013 Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.. 120:833-842. 2012 Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.. 120:1473-1484. 2012 Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.. 120:4197-4204. 2012 Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.. 120:3510-3518. 2012 Treatment-influenced associations of PML-RAR? mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.. 120:2098-2108. 2012 Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.. 116:3751-3757. 2010 Metnase mediates chromosome decatenation in acute leukemia cells.. 114:1852-1858. 2009
